AVP Gene Diabetes Insipidus Neurohypophyseal Genetic Test
At DNA Labs UAE, we offer the AVP Gene Diabetes Insipidus Neurohypophyseal Genetic Test for the diagnosis and management of diabetes insipidus. This test analyzes the AVP gene and other related genes using next-generation sequencing (NGS) technology.
Test Components
The AVP Gene Diabetes Insipidus Neurohypophyseal Genetic Test includes:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Before undergoing the AVP Gene Diabetes Insipidus Neurohypophyseal Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by diabetes insipidus and neurohypophyseal disorders.
Test Details
The AVP gene is responsible for encoding arginine vasopressin, also known as antidiuretic hormone (ADH). Diabetes insipidus is a condition characterized by excessive thirst and excessive urination due to a deficiency or insensitivity to ADH. The neurohypophyseal NGS genetic test utilizes next-generation sequencing technology to analyze the AVP gene and other genes related to neurohypophyseal disorders, including diabetes insipidus.
This test can identify mutations or variations in the AVP gene that may contribute to the development of diabetes insipidus. By analyzing the AVP gene, the neurohypophyseal NGS genetic test aids in diagnosing the specific genetic cause of diabetes insipidus and provides valuable information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of diabetes insipidus to determine if they carry a mutation in the AVP gene.
Overall, the neurohypophyseal NGS genetic test plays a crucial role in the genetic diagnosis and management of diabetes insipidus by identifying specific genetic mutations or variations in the AVP gene.
Test Name | AVP Gene Diabetes insipidus neurohypophyseal Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AVP Gene Diabetes insipidus, neurohypophyseal NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Diabetes insipidus, neurohypophyseal |
Test Details |
AVP gene refers to the gene that encodes for arginine vasopressin, also known as antidiuretic hormone (ADH). Diabetes insipidus is a condition characterized by excessive thirst and excessive urination due to a deficiency or insensitivity to ADH. Neurohypophyseal NGS genetic test is a genetic test that uses next-generation sequencing (NGS) technology to analyze the AVP gene and other related genes involved in neurohypophyseal disorders, including diabetes insipidus. This test can identify mutations or variations in the AVP gene that may be responsible for the development of diabetes insipidus. By analyzing the AVP gene, the neurohypophyseal NGS genetic test can help in diagnosing the specific genetic cause of diabetes insipidus and provide valuable information for genetic counseling and management of the condition. It can also be used for carrier testing in individuals with a family history of diabetes insipidus to determine if they carry a mutation in the AVP gene. Overall, the neurohypophyseal NGS genetic test plays a crucial role in the genetic diagnosis and management of diabetes insipidus by identifying specific genetic mutations or variations in the AVP gene. |